Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice
Authors:
- Emily M. BradfordEBEmily M. Bradford
- Gary E. ShullGSGary E. Shull
- Andreas R. JaneckeAJAndreas R. Janecke
- Peter Heinz-ErianPHPeter Heinz-Erian
- Thomas MüllerTMThomas Müller
- Jessica A. Dominguez RiegJRJessica A. Dominguez Rieg
- Samantha de la Mora ChavezSCSamantha de la Mora Chavez
- Timo RiegTRTimo Rieg
- Ali ShawkiASAli Shawki
- 1 April 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 296 (4) , G886-G898
Abstract
In cystic fibrosis, impaired secretion resulting from loss of activity of the cystic fibrosis transmembrane conductance regulator (CFTR) causes dehydration of intestinal contents and life-threatening obstructions. Conversely, impaired absorption resulting from loss of the NHE3 Na+/H+ exchanger causes increased fluidity of the intestinal contents and diarrhea. To test the hypothesis that reduced NHE3-mediated absorption could increase survival and prevent some of the intestinal pathologies of cystic fibrosis, Cftr/Nhe3 double heterozygous mice were mated and their offspring analyzed. Cftr-null mice lacking one or both copies of the NHE3 gene exhibited increased fluidity of their intestinal contents, which prevented the formation of obstructions and increased survival. Goblet cell hyperplasia was eliminated, but not the accumulation of Paneth cell granules or increased cell proliferation in the crypts. Microarray analysis of small intestine RNA from Cftr-null, NHE3-null, and double-null mice all revealed downregulation of genes involved in xenobiotic metabolism, including a cohort of genes involved in glutathione metabolism. Expression of energy metabolism genes was altered, but there were no changes in genes involved in inflammation. Total intracellular glutathione was increased in the jejunum of all of the mutants and the ratio of reduced to oxidized glutathione was reduced in Cftr-null mutants, indicating that CFTR deficiency affects intestinal glutathione metabolism. The data establish a major role for NHE3 in regulating the fluidity of the intestinal contents and show that reduced NHE3-mediated absorption reverses some of the intestinal pathologies of cystic fibrosis, thus suggesting that it may serve as a potential therapeutic target.Keywords
This publication has 69 references indexed in Scilit:
- Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung DiseaseThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Regulation by glucose and calcium of the carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting INS-1 cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Characteristic Multiorgan Pathology of Cystic Fibrosis in a Long-Living Cystic Fibrosis Transmembrane Regulator Knockout Murine ModelThe American Journal of Pathology, 2004
- Role for Cystic Fibrosis Transmembrane Conductance Regulator Protein in a Glutathione Response to Bronchopulmonary Pseudomonas InfectionInfection and Immunity, 2004
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- In Vivo Evidence for Interferon-γ-mediated Homeostatic Mechanisms in Small Intestine of the NHE3 Na+/H+ Exchanger Knockout Model of Congenital DiarrheaJournal of Biological Chemistry, 2002
- Drug Disposition in Cystic FibrosisClinical Pharmacokinetics, 1998
- Response of Rat Colonic Mucosa to a High Fiber DietAnnals of Nutrition and Metabolism, 1996
- Na+/H+ exchangers, NHE-1 and NHE-3, of rat intestine. Expression and localization.Journal of Clinical Investigation, 1994
- Intestinal Electrolyte Transport and Diarrheal DiseaseNew England Journal of Medicine, 1989